Skip to main content
. 2014 Aug 18;32(28):3137–3143. doi: 10.1200/JCO.2013.54.2456

Fig 1.

Fig 1.

Progression-free survival by Kaplan-Meier analysis for patients receiving combination treatment. Eleven patients experienced progressive disease or death after a median observation time of 21.4 months. Median progression-free survival was not reached (95% CI, 11.7 to NE). Circles on the plot indicate censored patients. Shaded area indicates the 95% CIs. NE, not estimable.